Back

Ischaemic mitral regurgitation: incidence, clinical and angiographic characteristics of 1000 patients with type 1 myocardial infarction undergoing percutaneous coronary intervention

31 August 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Echocardiography in Valvular Heart Disease: New Insights Valvular Heart Disease ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Harish Sharma

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
One-year echocardiographic outcomes of transcatheter aortic valve implantation with or without predilatation of the aortic valve: Insights from the multicenter, randomized DIRECT trial.
Doctor M. Karmpalioti (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Prognosis and clinical outcomes after TAVI, regarding the extravalvular cardiac damage defined by echocardiography prior the procedural.
Doctor J. Borrego Rodriguez (Bilbao, ES)
Abstract Slides Video
Presentation thumbnail
Flow rate and stroke volume index as predictors of mortality in patients undergoing transcatheter aortic valve implantation
Doctor S. Abdelrazek (Bad Krozingen, DE)
Abstract Slides Video
Presentation thumbnail
The five-beat averaged method of assessing aortic stenosis in atrial fibrillation significantly underestimates stenosis severity compared to sinus rhythm.
Doctor S. Tomlinson (Brisbane, AU)
Abstract Slides Video
Presentation thumbnail
Prognostic relevance of exercise pulmonary hypertension for new-onset atrial fibrillation in primary mitral regurgitation
Doctor K. Teramoto (Osaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Echocardiography in Valvular Heart Disease: New Insights

The Event

Event poster

ESC Congress 2020

31 August 2020 08:30 CET
You may be interested in
thumbnail
Congress Session
Failing valves and beyond
thumbnail
Congress Session
Acute heart failure and valvular heart disease
thumbnail
Congress Session
How to manage valvular heart disease in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources